newsfilter
← Latest News
GlobeNewswire·

Mycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPP

MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc. (OTC:TPIA) (the "Company"), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life Sciences (CSE:HAVN) (OTC:HAVLF).